Current and emerging antiviral treatments for hepatitis C infection. British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/j.1365-2125.2012.04419.x.Doyle JS, et al. Current and emerging antiviral treatments for hepatitis C infection. British Journal of Clinical Pharmacology. 2013;75(...
Fortunately, many new treatments have been introduced or are to be introduced in the near future. This article will review the basic concepts and the results of recent studies on the new treatments for chronic constipation.关键词: Hepatitis C virus Persons who inject drugsMethadone Sustained viral...
Current corticosteroid regimens are effective in autoimmune hepatitis, but therapy can be complicated by side effects, disease progression, incomplete resp... J Czaja,Albert - 《Current Pharmaceutical Design》 被引量: 65发表: 2011年 Current therapy for autoimmune hepatitis immunosuppressive treatmentsThe ...
In the treatment of CHC in children, it is likely that regimens using these DAAs will become the treatments of choice for patients who have access to them. This relies on the design of robust trials in order to provide evidence of effective, safe regimens that can be used in well-defined ...
If an individual is HIV positive, additional ART is needed for effective management, which is not discussed in this article. Laboratory work includes a complete metabolic panel, liver enzymes, renal function, hepatitis serology, and screening for sexually transmitted infections (STIs).13,15 TABLE ...
Importance Novel treatments for hepatitis C virus (HCV) infection are highly efficacious but costly... HS Chahal,EA Marseille,JA Tice,... - 《Jama Internal Medicine》 被引量: 74发表: 2015年 Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in ...
via a combination of small-molecule treatments with dimethyl sulfoxide. They stated that the small-molecule based approach is a simple, inexpensive and reproducible platform for the derivation of hepatocytes from hPSCs [182,195]. Itaba et al. screened 23 newly synthesized derivatives of small molecul...
Due to the high number of cases and the potential for severe disease development, the WHO has listed LASV as a priority pathogen, for which development of efficacious treatments and vaccines is urgently needed [13]. Along these lines, the Coalition for Epidemic Preparedness Innovations (CEPI) ...
The epidemiology of this cancer is unique since its risk factors, including hepatitis C and B, have been clearly established. The current trends in the shifting incidence of HCC in different regions of the world can be explained partly by the changing prevalence of hepatitis. Early detection ...
With its 78 million chronic carriers, hepatitis B virus (HBV) infection is still one of the leading public health challenges in China. Over the last two de